Immuno Oncology Assays Market Size, Share, and Industry Analysis By Product (Instruments and Consumables), By Technology (Immunoassay, Polymerase Chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry, and Others), By Cancer Type (Colorectal Cancer, Lung Cancer, Melanoma, and Others), By End User (Hospitals & Clinics, Academic and Research Institutes, and Others), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI111498

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Cancer, by Country/Region, 2025
2. Advancements in Immuno Oncology Assays
3. Key Industry Developments - (Mergers, Acquisitions & Partnerships)
Global Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Product
  2. Canada
    1. By Product
Europe Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By County/ Sub-region
  1. Germany
    1. By Product
  2. U.K.
    1. By Product
  3. France
    1. By Product
  4. Italy
    1. By Product
  5. Spain
    1. By Product
  6. Scandinavia
    1. By Product
  7. Rest of Europe
    1. By Product
Asia Pacific Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
    1. By Product
  2. India
    1. By Product
  3. Japan
    1. By Product
  4. Australia
    1. By Product
  5. Southeast Asia
    1. By Product
  6. Rest of Asia Pacific
    1. By Product
Latin America Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
    1. By Product
  2. Mexico
    1. By Product
  3. Rest of Latin America
    1. By Product
Middle East & Africa Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. South Africa
    1. By Product
  2. GCC
    1. By Product
  3. Rest of the Middle East & Africa
    1. By Product
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Thermo Fisher Scientific Inc.
  2. F. Hoffmann-La Roche Ltd
  3. Illumina, Inc.
  4. Agilent Technologies, Inc.
  5. Bio-Rad Laboratories, Inc.
  6. Danaher
  7. Merck KGaA
  8. QIAGEN
  9. Revvity
  10. 10x Genomics

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Cancer, by Country/Region, 2025
2. Advancements in Immuno Oncology Assays
3. Key Industry Developments - (Mergers, Acquisitions & Partnerships)
Global Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Product
  2. Canada
    1. By Product
Europe Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By County/ Sub-region
  1. Germany
    1. By Product
  2. U.K.
    1. By Product
  3. France
    1. By Product
  4. Italy
    1. By Product
  5. Spain
    1. By Product
  6. Scandinavia
    1. By Product
  7. Rest of Europe
    1. By Product
Asia Pacific Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
    1. By Product
  2. India
    1. By Product
  3. Japan
    1. By Product
  4. Australia
    1. By Product
  5. Southeast Asia
    1. By Product
  6. Rest of Asia Pacific
    1. By Product
Latin America Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
    1. By Product
  2. Mexico
    1. By Product
  3. Rest of Latin America
    1. By Product
Middle East & Africa Immuno Oncology Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instrument
  2. Consumables
2. Market Analysis, Insights and Forecast – By Technology
  1. Immunoassay
  2. Polymerase Chain Reaction (PCR)
  3. Next-Generation Sequencing (NGS)
  4. Immunohistochemistry (IHC)
  5. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnology Companies
  2. Contract Research Organizations (CROs)
  3. Academic & Research Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. South Africa
    1. By Product
  2. GCC
    1. By Product
  3. Rest of the Middle East & Africa
    1. By Product
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Thermo Fisher Scientific Inc.
  2. F. Hoffmann-La Roche Ltd
  3. Illumina, Inc.
  4. Agilent Technologies, Inc.
  5. Bio-Rad Laboratories, Inc.
  6. Danaher
  7. Merck KGaA
  8. QIAGEN
  9. Revvity
  10. 10x Genomics

Read Less

List of Figures

Figure 1: Global Immuno Oncology Assays Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034

Figure 2: Global Immuno Oncology Assays Market Value Share (%), by Product, 2025 & 2034

Figure 3: Global Immuno Oncology Assays Market Value Share (%), by Technology, 2025 & 2034

Figure 4: Global Immuno Oncology Assays Market Value Share (%), by Indication, 2025 & 2034

Figure 5: Global Immuno Oncology Assays Market Value Share (%), by End-user, 2025 & 2034

Figure 6: Global Immuno Oncology Assays Market Value (USD Billion), by Region, 2025 & 2034

Figure 7: North America Immuno Oncology Assays Market Value (USD Billion), by Product, 2025 & 2034

Figure 8: North America Immuno Oncology Assays Market Value Share (%), by Product, 2025

Figure 9: North America Immuno Oncology Assays Market Value (USD Billion), by Technology, 2025 & 2034

Figure 10: North America Immuno Oncology Assays Market Value Share (%), by Technology, 2025

Figure 11: North America Immuno Oncology Assays Market Value (USD Billion), by Indication, 2025 & 2034

Figure 12: North America Immuno Oncology Assays Market Value Share (%), by Indication, 2025

Figure 13: North America Immuno Oncology Assays Market Value (USD Billion), by End-user, 2025 & 2034

Figure 14: North America Immuno Oncology Assays Market Value Share (%), by End-user, 2025

Figure 15: North America Immuno Oncology Assays Market Value (USD Billion), By Country, 2025 & 2034

Figure 16: North America Immuno Oncology Assays Market Value Share (%), By Country, 2025

Figure 17: Europe Immuno Oncology Assays Market Value (USD Billion), by Product, 2025 & 2034

Figure 18: Europe Immuno Oncology Assays Market Value Share (%), by Product, 2025

Figure 19: Europe Immuno Oncology Assays Market Value (USD Billion), by Technology, 2025 & 2034

Figure 20: Europe Immuno Oncology Assays Market Value Share (%), by Technology, 2025

Figure 21: Europe Immuno Oncology Assays Market Value (USD Billion), by Indication, 2025 & 2034

Figure 22: Europe Immuno Oncology Assays Market Value Share (%), by Indication, 2025

Figure 23: Europe Immuno Oncology Assays Market Value (USD Billion), by End-user, 2025 & 2034

Figure 24: Europe Immuno Oncology Assays Market Value Share (%), by End-user, 2025

Figure 25: Europe Immuno Oncology Assays Market Value (USD Billion), By Country/Sub-region, 2025 & 2034

Figure 26: Europe Immuno Oncology Assays Market Value Share (%), By Country/Sub-region, 2025

Figure 27: Asia Pacific Immuno Oncology Assays Market Value (USD Billion), by Product, 2025 & 2034

Figure 28: Asia Pacific Immuno Oncology Assays Market Value Share (%), by Product, 2025

Figure 29: Asia Pacific Immuno Oncology Assays Market Value (USD Billion), by Technology, 2025 & 2034

Figure 30: Asia Pacific Immuno Oncology Assays Market Value Share (%), by Technology, 2025

Figure 31: Asia Pacific Immuno Oncology Assays Market Value (USD Billion), by Indication, 2025 & 2034

Figure 32: Asia Pacific Immuno Oncology Assays Market Value Share (%), by Indication, 2025

Figure 33: Asia Pacific Immuno Oncology Assays Market Value (USD Billion), by End-user, 2025 & 2034

Figure 34: Asia Pacific Immuno Oncology Assays Market Value Share (%), by End-user, 2025

Figure 35: Asia Pacific Immuno Oncology Assays Market Value (USD Billion), By Country/Sub-region, 2025 & 2034

Figure 36: Asia Pacific Immuno Oncology Assays Market Value Share (%), By Country/Sub-region, 2025

Figure 37: Latin America Immuno Oncology Assays Market Value (USD Billion), by Product, 2025 & 2034

Figure 38: Latin America Immuno Oncology Assays Market Value Share (%), by Product, 2025

Figure 39: Latin America Immuno Oncology Assays Market Value (USD Billion), by Technology, 2025 & 2034

Figure 40: Latin America Immuno Oncology Assays Market Value Share (%), by Technology, 2025

Figure 41: Latin America Immuno Oncology Assays Market Value (USD Billion), by Indication, 2025 & 2034

Figure 42: Latin America Immuno Oncology Assays Market Value Share (%), by Indication, 2025

Figure 43: Latin America Immuno Oncology Assays Market Value (USD Billion), by End-user, 2025 & 2034

Figure 44: Latin America Immuno Oncology Assays Market Value Share (%), by End-user, 2025

Figure 45: Latin America Immuno Oncology Assays Market Value (USD Billion), By Country/Sub-region, 2025 & 2034

Figure 46: Latin America Immuno Oncology Assays Market Value Share (%), By Country/Sub-region, 2025

Figure 47: Middle East & Africa Immuno Oncology Assays Market Value (USD Billion), by Product, 2025 & 2034

Figure 48: Middle East & Africa Immuno Oncology Assays Market Value Share (%), by Product, 2025

Figure 49: Middle East & Africa Immuno Oncology Assays Market Value (USD Billion), by Technology, 2025 & 2034

Figure 50: Middle East & Africa Immuno Oncology Assays Market Value Share (%), by Technology, 2025

Figure 51: Middle East & Africa Immuno Oncology Assays Market Value (USD Billion), by Indication, 2025 & 2034

Figure 52: Middle East & Africa Immuno Oncology Assays Market Value Share (%), by Indication, 2025

Figure 53: Middle East & Africa Immuno Oncology Assays Market Value (USD Billion), by End-user, 2025 & 2034

Figure 54: Middle East & Africa Immuno Oncology Assays Market Value Share (%), by End-user, 2025

Figure 55: Middle East & Africa Immuno Oncology Assays Market Value (USD Billion), By Country/Sub-region, 2025 & 2034

Figure 56: Middle East & Africa Immuno Oncology Assays Market Value Share (%), By Country/Sub-region, 2025

Figure 57: Global Immuno Oncology Assays Market Share (%), By Company, 2025

List of Tables

Table 1: Global Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 2: Global Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Technology, 2021–2034

Table 3: Global Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Indication, 2021–2034

Table 4: Global Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by End-user 2021–2034

Table 5: Global Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Region, 2021-2034

Table 6: North America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 7: North America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Technology, 2021–2034

Table 8: North America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Indication, 2021–2034

Table 9: North America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by End-user 2021–2034

Table 10: North America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, By Country, 2021-2034

Table 11: U.S. Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 12: Canada Immuno Oncology Assays Market Revenue (USD Billion) Forecast, By Product, 2021-2034

Table 13: Europe Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 14: Europe Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Technology, 2021–2034

Table 15: Europe Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Indication, 2021–2034

Table 16: Europe Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by End-user 2021–2034

Table 17: Europe Immuno Oncology Assays Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 18: Germany Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 19: U.K. Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 20: France Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 21: Italy Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 22: Spain Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 23: Scandinavia Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 24: Rest of Europe Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 25: Asia Pacific Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 26: Asia Pacific Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Technology, 2021–2034

Table 27: Asia Pacific Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Indication, 2021–2034

Table 28: Asia Pacific Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by End-user 2021–2034

Table 29: Asia Pacific Immuno Oncology Assays Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 30: China Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 31: India Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 32: Japan Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 33: Australia Pacific Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 34: Southeast Asia Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 35: Rest of Asia Pacific Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 36: Latin America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 37: Latin America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Technology, 2021–2034

Table 38: Latin America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Indication, 2021–2034

Table 39: Latin America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by End-user 2021–2034

Table 40: Latin America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 41: Brazil Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 42: Mexico Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 43: Rest of Latin America Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 44: Middle East & Africa Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 45: Middle East & Africa Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Technology, 2021–2034

Table 46: Middle East & Africa Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Indication, 2021–2034

Table 47: Middle East & Africa Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by End-user 2021–2034

Table 48: Middle East & Africa Immuno Oncology Assays Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 49: GCC Immuno Oncology Assays Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 50: South Africa Immuno Oncology Assays Market Revenue (USD Billion) Forecast, By Product, 2021-2034

Table 51: Rest of the Middle East & Africa Immuno Oncology Assays Market Revenue (USD Billion) Forecast, By Product, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 180

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com